Global Asthma & COPD Therapeutics Market 2019 Size, Trends, Industry Analysis, Leading Players & Future Forecast by 2025
May 3, 2019
WiseGuyReports.com adds “Asthma & COPD Therapeutics Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports to its database.
Pune, India - May 3, 2019 /MarketersMedia/ —
Executive Summary
Respiratory diseases refers to pathological condition affecting lungs and other parts of the respiratory system. Asthma and COPD are the two most common respiratory diseases. Chronic Obstructive Pulmonary Disease (COPD) term is collectively used to describe chronic lung diseases that cause limitations in lung airflow. Asthma is also a chronic lung disease that inflames and narrows the airways. Treatment paradigm of Asthma and COPD therapeutics comprises of anti-inflammatory drugs such as Corticosteroids, Bronchodilator Monotherapy such as Short-acting beta2-agonist (SABAs), Long-acting beta2-agonist (LABAs)), combination drugs, etc. Choice of therapeutics depends upon severity of the disease.
Asthma and COPD are leading chronic respiratory diseases with huge economic burden in both developed and developing countries. The disease represents a lucrative market due to continuous rise in prevalence of respiratory diseases, increasing environmental pollution, government initiatives, rise in number of smokers and growing geriatric population. However, the market faces several challenges due to stringent regulatory compliance, patent expiration of blockbuster drugs and associated side-effects of various therapeutics.
The report “Global Asthma & COPD Therapeutics Market (By Type - Anti-inflammatory drugs (Inhaled Corticosteroids (ICS), Bronchodilator Monotherapy (Short-acting beta2-agonist (SABAs), Long-acting beta2-agonist (LABAs)), Others; By Nation – The US, Germany, France, Japan & China)) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global Asthma & COPD market with market segmentation done across major therapeutic areas such as Anti-inflammatory drugs, Bronchodilator Monotherapy and Others.
Country analysis is done across various markets in the US, Germany, France, Japan & China. Future forecasts of Asthma & COPD Therapeutics market overall and across various sub-markets has been provided in the report till 2025. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global asthma and COPD therapeutics market include AstraZeneca plc, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Novartis AG, Merck & Co., Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global asthma and COPD therapeutics market.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3974979-global-asthma-copd-therapeutics-market-by-type-anti
Table of Content:
1. Executive Summary
2. Research Methodology
3. Respiratory Diseases
3.1 Background
3.2 Types
3.3 Asthma
3.3.1 Overview
3.3.2 Treatment
COPD
3.4.1 Overview
3.4.2 Treatment
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Disease
4.2.2 Market Share by Segments
4.2.3 Market Share by Therapeutic Classes
Figure: Global Asthma & COPD Market Share by Therapeutic Classes (2018)
4.2.4 Market Share by Nations
5. Treatment
5.1 Anti-inflammatory drugs
5.1.1 Inhaled Corticosteroids (ICS)
5.1.1.1 Overview
5.1.1.2 Market Sizing (Actual & Forecasted)
5.2 Bronchodilator Monotherapy
5.2.1 Long Acting Beta Agonists (LABA)
5.2.1.1 Overview
5.2.1.1 Market Sizing (Actual & Forecasted)
5.2.2 Short Acting Beta Agonists (SABA)
5.2.2.1 Overview
5.2.2.2 Market Sizing (Actual & Forecasted)
5.3 Others
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
6. Country Analysis
6.1 The US
6.1.1 Market Sizing (Actual & Forecasted)
6.2 Germany
6.2.1 Market Sizing (Actual & Forecasted)
6.3 France
6.3.1 Market Sizing (Actual & Forecasted)
6.4 Japan
6.4.1 Market Sizing (Actual & Forecasted)
6.5 China
6.5.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trends & Development
7.1.1 Connected Health Solutions
7.1.2 Higher Demand for Combination Therapies
7.1.3 Advent of Stem Cell Therapy
7.2 Growth Drivers
7.2.1 Prevalence of Respiratory Diseases
7.2.2 Environmental Pollution
7.2.3 Government Impetus
7.2.4 Rise in Number of Smokers
7.2.5 Growing Geriatric Population
7.3 Challenges
7.3.1 Stringent Regulatory Compliance
7.3.2 Patent Expiration of Drugs
7.3.3 Side-Effects of Drugs
8. Competitive Landscape
8.1 Drugs Clinical Pipeline
8.2 Financial Analysis
8.3 Market Share Analysis
9. Company Profiles
9.1 AstraZeneca plc
9.2 GlaxoSmithKline plc
9.3 F. Hoffmann-La Roche AG
9.4 Novartis AG
9.5 Merck & Co., Inc.
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/enquiry/3974979-global-asthma-copd-therapeutics-market-by-type-anti
Contact Info:
Name: Norah Trend
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1 (339) 368 6938 (US), +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com/reports/3974979-global-asthma-copd-therapeutics-market-by-type-anti
Source: MarketersMedia
Release ID: 508899
The world’s rich are turning inward. Southeast Asia’s entrepreneurs are packing their bags
For two decades, the startup gospel was simple: find product-market fit at home, then blitzscale across borders. In 2026, much of the world appears to be rethinking the second half of that sentence. According to HSBC’s Global Entrepreneurial Wealth Report (GEWR) 2026, the share of entrepreneurs globally who want to expand internationally fell six percentage […] The post The world’s rich are turning inward. Southeast Asia’s entrepreneurs are packing their bags appeared first on e27.
Bitcoin at US$82,829: Why a 95% correlation with the S&P 500 should worry long term believers
The digital asset landscape intertwines deeply with traditional equities rather than operating in isolation. The leading cryptocurrency recently climbed 1.67 per cent to reach US$82,829.06 over a single 24-hour period. This upward progression closely tracks a broad financial recovery. Risk assets worldwide are bouncing back from recent weakness. The digital sector mirrors this exact trajectory […] The post Bitcoin at US$82,829: Why a 95% correlation with the S&P 500 should worry long term believers appeared first on e27.
DeepSeek seeks ‘total victory’ over closed-source AI with new open-source tool
Chinese artificial intelligence start-up DeepSeek has fully open-sourced an internally developed framework designed to run AI models efficiently, as a senior researcher at the company described the growing divide between open-source and closed-source AI as a battle between “light and darkness”. The company on Tuesday released DeepInfer, an inference framework tailored to support its DeepSeek-V4.1-Flash model on both Nvidia’s SM100 Blackwell graphics processing units (GPUs) and Huawei...
Southeast Asia’s US$1T digital dream slips five years, and AI is the new reason to keep believing
Every October, Google, Temasek and Bain & Company gather Southeast Asia’s tech crowd around one seductive number. This year it is US$368 billion, the gross merchandise value (GMV) the region’s digital economy is projected to reach in 2026, up 17 per cent year-on-year. The longer-range promise is more than US$1 trillion by 2035. Long-time readers […] The post Southeast Asia’s US$1T digital dream slips five years, and AI is the new reason to keep believing appeared first on e27.
AFA Singapore 2026 brings Yuki Kajiura, May’n and Kyary Pamyu Pamyu to Suntec City
3 days of concerts, anime showcases and fan experiences await from 27 to 29 November.
Agentic AI is Singapore’s hottest job skill, and that should worry the people it replaces
Somewhere in Singapore this week, a recruiter is probably rewriting a job ad that once asked for “advanced Excel skills” so that it now asks for “hands-on experience with agentic AI workflows”. Multiply that by a few thousand listings and you arrive at the headline figure in Jobstreet by SEEK’s new AI Gauge. According to […] The post Agentic AI is Singapore’s hottest job skill, and that should worry the people it replaces appeared first on e27.
Vivo X500 Pro Max officially lands in Singapore *Updated*
Only the Vivo X500 and X500 Pro Max are coming to Singapore’s shores. Pre-order and pricing details within!
AI won’t tidy your business. It just moves the mess faster
I build AI tools for marketers, and run an AI marketing software firm in Singapore, so I spend a lot of time hearing about AI adoption. A recent talk by Robert Lai, founder of performance agency Kaliber, stuck with me because it opened with an uncomfortable claim: most of the AI work in the room […] The post AI won’t tidy your business. It just moves the mess faster appeared first on e27.
How I use AI to support public relations
After narrowly losing yet another pitch earlier this year, I added up the time I had spent preparing proposals: 300 hours in four months. I wanted to know whether we were pursuing the right business. Using Gemini and a script in Google Docs, I compared five years of proposals with our client invoicing records. One […] The post How I use AI to support public relations appeared first on e27.
I still work 40 hours a week. AI turns it into 120
I teach people how to use AI for a living. So you would expect me to tell you it does everything. It doesn’t. What it does is take a huge amount of the grind out of my week, as long as I stay in the loop. Most of what I have learned came from AI […] The post I still work 40 hours a week. AI turns it into 120 appeared first on e27.
PlayStation marks 30 years of Gran Turismo with a limited edition DualSense controller
Arriving on 10 December, the cool-looking controller features racing stripes and a textured carbon-fibre-style finish.
Malaysia’s US$110M startup bet has a matching problem, investors warn
Malaysia has found the money for its startups again. The harder part, investors say, is finding everything that is supposed to come with it. In his Budget 2027 speech on 9 October, Prime Minister and Finance Minister Anwar Ibrahim said Khazanah’s Jelawang Capital and KWAP’s Dana Perintis would invest MYR450 million (US$110.4 million) in startups. […] The post Malaysia’s US$110M startup bet has a matching problem, investors warn appeared first on e27.
2026 is the year AI is pushed to production
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.